TY - JOUR
T1 - Multidimensional outlook on the pathophysiology of cervical cancer invasion and metastasis
AU - George, Neena
AU - Bhandari, Poonam
AU - Shruptha, Padival
AU - Jayaram, Pradyumna
AU - Chaudhari, Sima
AU - Satyamoorthy, Kapaettu
N1 - Funding Information:
Authors thank Manipal Academy of Higher Education, Manipal, Technology Information Forecasting Assessment Council—Centre of Relevance and Excellence in Pharmacogenomics (TIFAC-CORE), and Department of Science and Technology—Science for Equity, Empowerment and Development division (DST-SEED), for the support. We thank Indian Council of Medical Research for the Senior Research Fellowships (ICMR-SRF) to Sima Chaudhari, Neena George and Pradyumna Jayaram (Sanction ID: BMI/11(107)/2020). We thank Lady TATA Memorial Trust Junior Research fellowship to Shruptha Padival.
Publisher Copyright:
© 2023, The Author(s).
PY - 2023
Y1 - 2023
N2 - Cervical cancer being one of the primary causes of high mortality rates among women is an area of concern, especially with ineffective treatment strategies. Extensive studies are carried out to understand various aspects of cervical cancer initiation, development and progression; however, invasive cervical squamous cell carcinoma has poor outcomes. Moreover, the advanced stages of cervical cancer may involve lymphatic circulation with a high risk of tumor recurrence at distant metastatic sites. Dysregulation of the cervical microbiome by human papillomavirus (HPV) together with immune response modulation and the occurrence of novel mutations that trigger genomic instability causes malignant transformation at the cervix. In this review, we focus on the major risk factors as well as the functionally altered signaling pathways promoting the transformation of cervical intraepithelial neoplasia into invasive squamous cell carcinoma. We further elucidate genetic and epigenetic variations to highlight the complexity of causal factors of cervical cancer as well as the metastatic potential due to the changes in immune response, epigenetic regulation, DNA repair capacity, and cell cycle progression. Our bioinformatics analysis on metastatic and non-metastatic cervical cancer datasets identified various significantly and differentially expressed genes as well as the downregulation of potential tumor suppressor microRNA miR-28-5p. Thus, a comprehensive understanding of the genomic landscape in invasive and metastatic cervical cancer will help in stratifying the patient groups and designing potential therapeutic strategies.
AB - Cervical cancer being one of the primary causes of high mortality rates among women is an area of concern, especially with ineffective treatment strategies. Extensive studies are carried out to understand various aspects of cervical cancer initiation, development and progression; however, invasive cervical squamous cell carcinoma has poor outcomes. Moreover, the advanced stages of cervical cancer may involve lymphatic circulation with a high risk of tumor recurrence at distant metastatic sites. Dysregulation of the cervical microbiome by human papillomavirus (HPV) together with immune response modulation and the occurrence of novel mutations that trigger genomic instability causes malignant transformation at the cervix. In this review, we focus on the major risk factors as well as the functionally altered signaling pathways promoting the transformation of cervical intraepithelial neoplasia into invasive squamous cell carcinoma. We further elucidate genetic and epigenetic variations to highlight the complexity of causal factors of cervical cancer as well as the metastatic potential due to the changes in immune response, epigenetic regulation, DNA repair capacity, and cell cycle progression. Our bioinformatics analysis on metastatic and non-metastatic cervical cancer datasets identified various significantly and differentially expressed genes as well as the downregulation of potential tumor suppressor microRNA miR-28-5p. Thus, a comprehensive understanding of the genomic landscape in invasive and metastatic cervical cancer will help in stratifying the patient groups and designing potential therapeutic strategies.
UR - http://www.scopus.com/inward/record.url?scp=85149761100&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85149761100&partnerID=8YFLogxK
U2 - 10.1007/s11010-023-04686-3
DO - 10.1007/s11010-023-04686-3
M3 - Review article
AN - SCOPUS:85149761100
SN - 0300-8177
JO - Enzymologia
JF - Enzymologia
ER -